Intrinsic Value of S&P & Nasdaq Contact Us

Henry Schein, Inc. HSIC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
51/100
1/7 Pass
SharesGrow Intrinsic Value
$147.54
+91.1%
Analyst Price Target
$90.17
+16.8%

Henry Schein, Inc. (HSIC) — Analyst outlook / Analyst consensus target is. Based on 32 analyst ratings, the consensus is bullish — 14 Buy, 15 Hold, 3 Sell.

The consensus price target is $90.17 (low: $81.00, high: $100.00), representing an upside of 16.8% from the current price $77.20.

Analysts estimate Earnings Per Share (EPS) of $4.75 and revenue of $12.76B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $3.08 vs est $4.75 (missed -35.2%). 2025: actual $3.29 vs est $4.92 (missed -33.1%). Analyst accuracy: 48%.

HSIC Stock — 12-Month Price Forecast

$90.17
▲ +16.80% Upside
Average Price Target
Based on 32 Wall Street analysts offering 12-month price targets for Henry Schein, Inc., the average price target is $90.17, with a high forecast of $100.00, and a low forecast of $81.00.
The average price target represents a +16.80% change from the last price of $77.20.
Highest Price Target
$100.00
Average Price Target
$90.17
Lowest Price Target
$81.00

HSIC Analyst Ratings

Hold
32
Ratings
14 Buy
15 Hold
3 Sell
Based on 32 analysts giving stock ratings to Henry Schein, Inc. in the past 3 months
Rating breakdown
Buy
14 44%
Hold
15 47%
Sell
3 9%
44%
Buy
14 analysts
47%
Hold
15 analysts
9%
Sell
3 analysts

EPS Estimates — HSIC

48%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $3.08 vs Est $4.75 ▼ 54.3% off
2025 Actual $3.29 vs Est $4.92 ▼ 49.5% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — HSIC

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $12.673B vs Est $12.764B ▼ 0.7% off
2025 Actual $13.184B vs Est $13.089B ▲ 0.7% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message